Navin Balaj, MD
Consultant - Strategy & Healthcare
Bridging Clinical Expertise with Strategic Insight
Dr. Navin Balaj merges firsthand clinical experience with high-impact consulting acumen. A physician entering Radiation Oncology residency at the University of Miami’s Miller School of Medicine, Navin previously served McKinsey & Company’s Healthcare and Life Sciences practices—driving strategic transformations for biopharma, health systems, and digital health ventures.
Navin’s Areas of Expertise:
Biopharma Strategy & Market Access: Designed launch sequencing, pricing models, and market-entry plans for novel therapeutics, supporting optimal uptake across payer and provider channels
Health System Operations: Led performance-improvement and cost-reduction initiatives within hospital networks, optimizing care pathways and resource allocation
Digital Health & Health Tech: Advised growth-stage startups on product -market fit, scaling roadmaps, and reimbursement strategies, integrating clinical workflows with technology platforms
Clinical & Regulatory Pathways: Navigated FDA and payer landscapes -crafting trial designs, value dossiers, and stakeholder engagement plans to accelerate regulatory approval and commercialization
Health Economics & Outcomes Research: Directed cost-effectiveness analyses and real-world evidence studies to quantify value propositions and inform reimbursement decisions